2011 Street Expectations Moderating
UBS Investment Research reports: “Given compelling clinical benefit, we remain optimistic on long-term LVAD opportunity but admit uncertainty as to mid-term trajectory.”
UBS Investment Research reports: “Given compelling clinical benefit, we remain optimistic on long-term LVAD opportunity but admit uncertainty as to mid-term trajectory.”